268 related articles for article (PubMed ID: 18360853)
1. Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?
Shaikh F; Maddikunta R; Djelmami-Hani M; Solis J; Allaqaband S; Bajwa T
Catheter Cardiovasc Interv; 2008 Apr; 71(5):614-8. PubMed ID: 18360853
[TBL] [Abstract][Full Text] [Related]
2. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
[TBL] [Abstract][Full Text] [Related]
3. Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents.
Kim JS; Lee SY; Lee JM; Yoon YW; Ahn CM; Kim MH; Min PK; Ko YG; Hong BK; Choi D; Kwon HM; Jang Y; Shim WH
Coron Artery Dis; 2009 Jan; 20(1):59-63. PubMed ID: 19008765
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
[TBL] [Abstract][Full Text] [Related]
5. Stent strut fracture: seeing is believing.
Carter AJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
[No Abstract] [Full Text] [Related]
6. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
7. Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial.
Park SM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Kang WC; Ahn T; Kim BK; Oh SJ; Jeon DW; Yang JY
Catheter Cardiovasc Interv; 2011 Jan; 77(1):15-21. PubMed ID: 20928842
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
Lee MS; Tarantini G; Xhaxho J; Yang T; Ehdaie A; Bhatia R; Favaretto E; Tobis J
JACC Cardiovasc Interv; 2010 Apr; 3(4):378-82. PubMed ID: 20398863
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy.
Cilingiroglu M; Chilakapati V; Dunlap S; Leesar MA
Cardiovasc Revasc Med; 2010; 11(2):120-3. PubMed ID: 20347805
[TBL] [Abstract][Full Text] [Related]
10. Late restenosis following sirolimus-eluting stent implantation.
Kuriyama N; Kobayashi Y; Nakama T; Mine D; Nishihira K; Shimomura M; Nomura K; Ashikaga K; Matsuyama A; Shibata Y
JACC Cardiovasc Interv; 2011 Jan; 4(1):123-8. PubMed ID: 21251639
[TBL] [Abstract][Full Text] [Related]
11. Do drug elution components increase the risk of fracture of sirolimus-eluting stents?
Kawai T; Umeda H; Ota M; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Matsui S; Ishii J; Hishida H; Ozaki Y
Coron Artery Dis; 2010 Aug; 21(5):298-303. PubMed ID: 20617542
[TBL] [Abstract][Full Text] [Related]
12. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
[TBL] [Abstract][Full Text] [Related]
13. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Vlaar PJ; Zijlstra F
JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
[No Abstract] [Full Text] [Related]
14. Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients.
Miyai N; Kinoshita N; Oota K; Yamada T; Nakamura R; Irie H; Hashimoto T; Tamaki S; Matsubara H
Heart Vessels; 2011 Mar; 26(2):168-75. PubMed ID: 20978891
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ
JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
[TBL] [Abstract][Full Text] [Related]
18. Choice of stent and outcomes after treatment of drug-eluting stent restenosis in highly complex lesions.
Freixa X; Almasood AS; Khan SQ; Mackie K; Osten M; Ing D; Overgaard CB; Horlick EM; Seidelin PH; Džavík V
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E16-22. PubMed ID: 22511403
[TBL] [Abstract][Full Text] [Related]
19. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials.
Qian J; Chen Z; Ma J; Ge J
Catheter Cardiovasc Interv; 2012 Oct; 80(4):507-13. PubMed ID: 22045690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]